Ethyl 4-chloro-6-methoxyquinoline-3-carboxylate, 95.0%, 250mg

1-CHLORO-6-METHYL-5-NITROISOQUINOLINE, 95.0%, 5g

3-ethyl-5-[(2S)-2-pyrrolidinyl]-1,2,4-oxadiazole, 95.0%, 250mg

N-(Furan-2-ylmethyl)-3,4-dimethylaniline, 97%, 5g

Boîtes de Pétri avec oreilles d'aération, 90 x 16 mm, Stériles 480 pcs

2-((2,6-DICHLORO-4-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYL)AMINO)-N-HYDROXYBENZAMIDE, 95%, 10mg

2-Bromo-6-methylanisole, 95.0%, 5g

(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid, 97%, 500g

5-CHLORO-2-FLUORO-4-HYDROXYBENZALDEHYDE, 95.0%, 5g

(3-Chloropyridin-4-yl)methanamine, 98%, 1g

3-(4-PROPOXYPHENYL)PROPAN-1-OL, 95.0%, 250mg

2-Bromo-3-chloropyridin-4-amine, 95.0%, 5g

Methyl 2-nitroacetate, 95.0%, 10g